GNS Healthcare

GNS Healthcare applies a powerful form of AI called causal machine learning to predict which treatments will work for which patients, improving individual patient outcomes and the health of populations, while reducing the total cost of care. Headquartered in Cambridge, MA, our patented REFS? technology is based on recent breakthroughs in causal machine learning and AI that transforms patient data into computer models of disease at molecular, patient, and health system levels. These computer models power up solutions, products, and services that health plans, biopharmaceutical companies, health systems, and patient foundations utilize to slow disease progression, reduce adverse events and hospitalization, and improve therapeutic effectiveness. Our platforms and solutions have been validated across more than 35 diseases including oncology, cardiovascular and metabolic disease, autoimmune diseases, neurology, etc. and have appeared in over 40 peer-reviewed publications. Mission:?GNS's mission is to make the precise matching of interventions to individuals possible by creating data-driven evidence to define what works for whom and to place that knowledge within reach for health plans, health systems, biopharmaceutical companies, and foundations and researchers who are working toward improving health outcomes, patient by patient.